CureSight Oculi Pigri Curatio Fabrica ab Kobi Kor

Opus CureSight Oculi Pigri Curatio Fabrica a designatore Kobi Kor est victor maxime honoratus praemii praestigiosissimi 2022 Praemium A' Design Award Ferreum in Categoria Certaminis Productum Medicum.

FerrumProductum Medicum· 2022

CureSight Oculi Pigri Curatio Fabrica

a Kobi Kor

Cliens: Novasight

Victor praemii Praemium A' Design Award Ferreum in Categoria Productum Medicum

22,237

Victor Praemii Verificatus

Verifica Statum Praemii pro #133911

Inveni Nunc Visita Situm Vide apud A' Design Award Communicatum Insigne Praemii

Colores

Designum

De CureSight Oculi Pigri Curatio Fabrica

Consilium processus CureSight feruntur in creando productum et solutionem curationis, quae positivum ictum socialem faciet et aegros adiuvabit, quorum plerique pueri sunt, ne incommoditatem et verecundiam in traditionalem curationem cum CULCITRA versari. Consilium etiam effert productum ' aspectum et sensum esse essentialem in motivo et permittente haedos. Inspiratio ad consilium ferendi ab tech gadgetibus orta est, qui haedos amant uti et ludere cum eo. Figura designationis lubricum et modernum quaesitum pro arte medicinae productum praebet.

Agnitio

De Praemium A' Design Award Ferreum

CureSight Oculi Pigri Curatio Fabrica victor est Praemii A' Design Award Ferreum, honoris amplissimi formis bonis dati, quae postulatis professionalibus et industrialibus ab creationibus bene formatis exspectatis satisfaciunt. Victores Ferrei magnam peritiam, altam specializationem, intellectum periti et facultatem creandi auctorum suorum ostendunt. Exspectatur CureSight Oculi Pigri Curatio Fabrica creationem multum aestimatam, admiratam et carissimam, practicam et novam fore. Haec forma Ferreo victa optimas industriae consuetudines integrat et proprietates technicas idoneas, cum scientia et talento coniunctas, habet. CureSight Oculi Pigri Curatio Fabrica ob diligentiam suam honoratur et ad vitae qualitatem emendandam formatum est, ut mundum meliorem reddere iuvet.

Post Designum

Fasciculus Nuntii

Merita, sodales gregis et singula technica a designatore praebita.

Proprietates Singulares: The curesight is a powerful solution with great potential to totally change the treatment of lazy eye condition, with the important advantage of treating the lazy eye from the comfort of home and by watching any tv or streaming video content.
This healthcare solution for lazy eye condition integrates high-end technologies for eye-tracking and ai software tools for smart analyzing of the lazy eye condition and providing personal custom treatment. The gold standard care for lazy eye is placing a patch over the strong eye, an old-fashioned solution that suffers from very low compliance.
Dimensiones et Involucrum: product net dimensions
Height 230mm
Width 390mm
Depth 60mm
Notulae: amlyopia, lazy eye, medical device, product design, social impact, degital healthcare
Technologia Productionis: The design activity started with a brainstorming meeting to learn more about the problem from the clinical and user needs aspects, and to outline the main big limitations of today's treatment methods.
We also discussed the ergonomics and usability needs to be able to provide the best treatment.
during the design process, we tested several design concepts both aesthetically and with physical mockups,
Production technologies include aluminum CNC machining and anodize plating, for the front bezel and plastic injection for the back cover and small covers.
Provocatio Designandi: The creative challenge was to dress the unique technology components with style and to provide a good user experience to the users, the specific usability needs to enable good treatment for various populations and make it an appealing and empowering treatment device, and lead to important social impact
Investigatio: Following an intense effort over the last 18 months, the company officially announced that the company successfully met the primary endpoint of the CureSight randomized, controlled pivotal trial of amblyopia treatment against the gold standard patching.
This is the first-ever pivotal study in which a digital device was shown to be non-inferior to eye patching for amblyopia treatment in children.
The study also exhibited 93% adherence to the curesight treatment, as well as a 93% likelihood of the parents choosing curesight over patching.
Inspiratio: The inspiration for the curesight product started from a personal experience when one of my kids needed to treat the lazy eye condition with the eye patch solution, I learned from this experience about the discomfort of wearing the eye patch for a few hours every day and especially how embarrassing it is from the social point of view.
The inspiration for the styling design came from the tech gadgets that kids love to use and play with, to provide a slick and modern design to a medical device product type, the front aluminum bezel, and the back swallowtail gives the product a clean gadget look.
Duratio Operis: The project started in 2019 in Tel Aviv, and finished in late 2021, the project was exhibited at the CES in January 2020 in Las Vegas
Cursus Operationis: The patient, most likely kids will have the fun be treated by the Curesight while watching any video content they love to watch without any degradation in quality and from the comfort of home.
Membra Turmae: Kobi Kor
Tal Samet
Agnitiones Imaginum: All images
Photograph and Illustrations: Novasight and Kobi Kor